WordNet

a light soft silver-white metallic element of the alkali metal group; oxidizes rapidly in air and reacts violently with water; is abundant in nature in combined forms occurring in sea water and in carnallite and kainite and sylvite (同)K, atomic number 19

PrepTutorEJDIC

ポタシウム,カリウム(金属元素;化学記号はK)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. アレルギー性結膜炎：マネージメントallergic conjunctivitis management [show details]
…name]), nedocromil (Alocril [brand name]), lodoxamide tromethamine (Alomide [brand name]), and pemirolast (Alamast [brand name]). Full efficacy is reached 5 to 14 days after therapy has been initiated, and…
2. 全身化学療法に対する輸注反応infusion reactions to systemic chemotherapy [show details]
…unless there are extenuating circumstances. At least some data suggest that prophylactic use of pemirolast, an oral mast cell stabilizing agent, may decrease the incidence of paclitaxel-induced infusion …
3. 巨大乳頭結膜炎giant papillary conjunctivitis [show details]
…stabilizers, and dual-acting agents (eg, olopatadine, azelastine hydrochloride, epinastine, pemirolast potassium, and ketotifen fumarate) can all provide relief of acute itching and reduce eye rubbing by…
4. 春季カタルvernal keratoconjunctivitis [show details]
…allergic response. Dual-acting agents include olopatadine, azelastine hydrochloride, epinastine, pemirolast potassium, and ketotifen fumarate (this last option is available in a generic formulation and is over…
5. 無症候性腹部大動脈瘤のマネージメントmanagement of asymptomatic abdominal aortic aneurysm [show details]
…stabilizing agents in patients with small AAAs. However, a trial that randomized 326 patients to pemirolast or placebo found no significant differences in small AAA (3.0 to 4.9 cm) expansion rates (mean…

English Journal

Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis.

Castillo M1, Scott NW, Mustafa MZ, Mustafa MS, Azuara-Blanco A.
The Cochrane database of systematic reviews.Cochrane Database Syst Rev.2015 Jun 1;6:CD009566. doi: 10.1002/14651858.CD009566.pub2.
BACKGROUND: Seasonal/perennial allergic conjunctivitis is the most common allergic conjunctivitis, usually with acute manifestations when a person is exposed to allergens and with typical signs and symptoms including itching, redness, and tearing. The clinical signs and symptoms of allergic conjunct
PMID 26028608

[Toxicity of topical ocular anti-allergic agents on human corneal epithelial cells in vitro].

Li J1, Yan XM.
[Zhonghua yan ke za zhi] Chinese journal of ophthalmology.Zhonghua Yan Ke Za Zhi.2010 Jan;46(1):43-50.
OBJECTIVE: To investigate the cytotoxic effect of three kinds of topical ocular anti-allergic agent, including olopatadine 0.1% (A group), ketotifen fumarate 0.025% (B group) and pemirolast potassium 0.1% (C group), on cultured human corneal epithelial cells in vitro.METHODS: Primary human corneal e
PMID 20388322

Suppressive activity of pemirolast potassium, an antiallergic drug, on glomerulonephritis. Studies in glomerulonephritis model rats and in patients with chronic glomerulonephritis concurrently affected by allergic rhinitis.

Gohda T1, Ra C, Hamada C, Tsuge T, Kawachi H, Tomino Y.
Arzneimittel-Forschung.Arzneimittelforschung.2008;58(1):18-23. doi: 10.1055/s-0031-1296461.
BACKGROUND: It is still difficult to manage chronic glomerulonephritis with corticosteroids because of safety concerns, especially for patients with mild symptoms and infants. Therefore, an alternative approach is greatly required. Pemirolast potassium (CAS 100299-08-9) is an antiallergic drug with
PMID 18368946